Verification of The Cloud DX Vitaliti™ Continuous Vital Sign Monitor (CVSM): Non-invasive Blood Pressure Component
Verification Protocol for The Cloud DX Vitaliti™ Continuous Vital Sign Monitor (CVSM): Non-invasive Blood Pressure Component for Clinical Use and Self Measurement According to the American Safety in Medical Technology and the IEEE
1 other identifier
interventional
78
1 country
1
Brief Summary
The purpose of this study is the verification of Cloud-DX Vitaliti™ Continuous Automated Non-Invasive Blood Pressure Monitor for Clinical Use and Self Measurement according to standards laid out by IEEE Std 1708 and AAMI-ISO 81060-2.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Aug 2018
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 16, 2018
CompletedFirst Posted
Study publicly available on registry
April 11, 2018
CompletedStudy Start
First participant enrolled
August 9, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 6, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
November 6, 2019
CompletedMarch 3, 2020
March 1, 2020
1.2 years
March 16, 2018
March 2, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Blood pressure
Determining the accuracy of non-invasive blood pressure measurement compared to invasive blood pressure. A detailed analysis will be conducted on the invasive blood pressure to verify accuracy as defined in the ISO 81060-2 Standard.
30 minutes
Study Arms (1)
Vitaliti
OTHERThe subject's blood pressure will be simultaneously determined and recorded using the invasive arterial line blood pressure reading and the test Vitaliti device readings.
Interventions
Measurements recorded by the Vitaliti device will be compared to the recordings from the arterial catheter.
Eligibility Criteria
You may qualify if:
- Patients ≥18 years of age;
- Patient has undergone major cardiac or vascular surgery and has been admitted post-op to the cardiac surgical intensive care unit (CICU) or vascular surgery step down unit with an arterial line in place
You may not qualify if:
- Patients \< 18 years of age;
- Pregnant;
- Current arrhythmia
- Blood pressure outside of test range for phase (refer to table 1)
- Allergy to device contact adhesive (e.g. ECG leads)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hamilton General Hospital
Hamilton, Ontario, L8L 2X2, Canada
Related Publications (1)
McGillion MH, Dvirnik N, Yang S, Belley-Cote E, Lamy A, Whitlock R, Marcucci M, Borges FK, Duceppe E, Ouellette C, Bird M, Carroll SL, Conen D, Tarride JE, Harsha P, Scott T, Good A, Gregus K, Sanchez K, Benoit P, Owen J, Harvey V, Peter E, Petch J, Vincent J, Graham M, Devereaux PJ. Continuous Noninvasive Remote Automated Blood Pressure Monitoring With Novel Wearable Technology: A Preliminary Validation Study. JMIR Mhealth Uhealth. 2022 Feb 28;10(2):e24916. doi: 10.2196/24916.
PMID: 34876396DERIVED
Study Officials
- PRINCIPAL INVESTIGATOR
Michael McGillion, RN, PhD
School of Nursing, Faculty of Health Sciences, McMaster University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor and Assistant Dean
Study Record Dates
First Submitted
March 16, 2018
First Posted
April 11, 2018
Study Start
August 9, 2018
Primary Completion
November 6, 2019
Study Completion
November 6, 2019
Last Updated
March 3, 2020
Record last verified: 2020-03